Want to discover more about the combined experience and data with ICLUSIG? Click the link below
to download a concise and informative ICLUSIG infographic.
CML, chronic myeloid leukaemia;
Ph+ ALL, Philadelphia chromosome-positive acute lymphoblastic leukaemia.
1. Cortes JE, et al. Blood. 2018;132:393–404;
2. Cortes J, et al. Blood. 2021;138:2042–50.
Date of preparation: June 2023
© 2023, Incyte. All rights reserved.
Marketing authorisation holder: Incyte Biosciences Norway AS.
ICLUSIG, the ICLUSIG logo and the Incyte logo are registered trademarks of Incyte.
If you would like to request further medical information, please visit:
You are now leaving iclusig.eu. This link will take you to a site that is not owned or maintained
by Incyte, and Incyte is not responsible for the information contained on third-party sites.
Please select from the following:
This website is intended for healthcare professionals located in Europe only.
Are you a healthcare professional located in Europe?